Inspire Medical Systems, Inc. (INSP) — Fair Value Analysis

Base-case fair value (P50): $50.36 · Current price: $50.21 · Verdict: Fairly Valued

The Verdict on INSP

Inspire Medical Systems Inc (INSP) is currently assessed as Fairly Valued based on our comprehensive Monte Carlo simulations. With the stock trading at $50.21, our median fair value (P50) stands at $50.36, indicating a marginal +0.3% from the current level. This output suggests that INSP's market price closely aligns with its intrinsic valuation derived from thousands of simulated forward scenarios, leading to the "Fairly Valued" verdict. The precise convergence between $50.21 and our P50 fair value implies that the market is largely efficient in its current pricing of INSP according to our model, with very limited immediate statistical upside.

How INSP stacks up against peers

While our proprietary quality tier for INSP is currently unrated, which limits a direct comparative analysis of its operational and financial health against specific sector peers, the Monte Carlo simulation provides an independent and robust valuation perspective. Despite the unrated quality tier, the model's output for INSP consistently points to a P50 fair value of $50.36, tracking closely with its $50.21. This robust, data-driven methodology accounts for various market dynamics and company-specific variables inherent to INSP, offering a clear valuation anchor. The minimal +0.3% gap underscores that INSP's valuation is well-understood by the market in the context of our simulations, irrespective of qualitative peer comparisons.

What this means for investors

For investors tracking INSPIRE MEDICAL SYSTEMS INC, the "Fairly Valued" verdict is a key takeaway. The close alignment between $50.21 and the $50.36 fair value, reflected in the marginal +0.3%, suggests a balanced risk-reward profile at the current juncture based on our analysis. This indicates that, according to our Monte Carlo simulations, the market effectively prices in INSP's future prospects and inherent volatility. While current valuation shows little immediate statistical upside, understanding the full range of potential outcomes is crucial. For a comprehensive view of INSP's bear and bull case distributions and to track its fair value as new fundamental data is released, sign up for a free FairCurve account today.